Blood Cell Count Derived Inflammation Indexes in Patients with Idiopathic Pulmonary Fibrosis.


Journal

Lung
ISSN: 1432-1750
Titre abrégé: Lung
Pays: United States
ID NLM: 7701875

Informations de publication

Date de publication:
10 2020
Historique:
received: 24 05 2020
accepted: 10 08 2020
pubmed: 28 8 2020
medline: 21 8 2021
entrez: 27 8 2020
Statut: ppublish

Résumé

Inflammation and immunity play a pivotal but yet unclear role in idiopathic pulmonary fibrosis (IPF), a chronic disorder characterized by progressive damage of lung parenchyma and severe loss of lung function despite optimal treatment. However, the pathophysiological and predictive role of combined blood cell count indexes of inflammation in IPF is uncertain. Seventy-three patients with IPF and 62 healthy subjects matched for age, gender and smoking status were included in this cross-sectional study. We found significant differences in neutrophil to lymphocyte ratio (NLR), derived neutrophil to lymphocyte ratio (dNLR), monocyte to lymphocyte ratio (MLR), platelet to lymphocyte ratio (PLR), systemic inflammation response index (SIRI) and aggregate index of systemic inflammation (AISI) between IPF patients and healthy controls. In logistic regression, all combined blood inflammation indexes, barring PLR, were independently associated with the presence of IPF after adjusting for age, gender, body mass index and smoking status. Furthermore, significant associations between FVC% and NLR, LMR, SIRI and AISI, and between DLCO% and NLR, dNLR, LMR, SIRI and AISI, were observed. In conclusion, our data indicate significant alterations of combined blood cell count indexes of inflammation in IPF.

Identifiants

pubmed: 32844257
doi: 10.1007/s00408-020-00386-7
pii: 10.1007/s00408-020-00386-7
pmc: PMC7502432
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

821-827

Références

Nat Rev Immunol. 2006 Mar;6(3):173-82
pubmed: 16498448
Cancer Manag Res. 2020 Mar 03;12:1543-1567
pubmed: 32184659
Cancer Immunol Immunother. 2018 Sep;67(9):1349-1353
pubmed: 29947960
Eur Respir J. 2012 Dec;40(6):1475-82
pubmed: 22441751
Respir Med. 2019 Feb;147:79-91
pubmed: 30704705
J Leukoc Biol. 2015 Aug;98(2):143-52
pubmed: 25743626
Eur Respir J. 2005 Jul;26(1):1-2
pubmed: 15994380
Clin Exp Med. 2019 Feb;19(1):37-45
pubmed: 30478648
N Engl J Med. 2004 Jan 8;350(2):125-33
pubmed: 14711911
Lancet. 2012 Aug 18;380(9842):680-8
pubmed: 22901889
Am J Respir Crit Care Med. 1998 Mar;157(3 Pt 1):762-8
pubmed: 9517588
Sarcoidosis Vasc Diffuse Lung Dis. 2003 Jun;20(2):138-43
pubmed: 12870724
Respir Res. 2005 Jul 24;6:81
pubmed: 16042790
Nature. 2017 Jan 5;541(7635):96-101
pubmed: 28002407
Eur Respir Rev. 2018 Feb 7;27(147):
pubmed: 29436405
Crit Rev Immunol. 2012;32(6):463-88
pubmed: 23428224
Eur J Clin Invest. 2019 Jan;49(1):e13037
pubmed: 30316204
Respir Res. 2002;3:3
pubmed: 11806838
Eur J Clin Invest. 2018 Aug;48(8):e12984
pubmed: 29924383
Am J Respir Crit Care Med. 2011 Mar 15;183(6):788-824
pubmed: 21471066
PLoS One. 2015 Jan 15;10(1):e0116775
pubmed: 25590613
Ann Allergy Asthma Immunol. 2019 Mar;122(3):337-339.e1
pubmed: 30508585
Cancer. 2016 Jul 15;122(14):2158-67
pubmed: 27152949
Am J Respir Crit Care Med. 2015 Jul 15;192(2):e3-19
pubmed: 26177183
Immunity. 2017 Nov 21;47(5):890-902.e4
pubmed: 29166589
J Exp Med. 2011 Jul 4;208(7):1339-50
pubmed: 21727191
J Cell Biol. 2015 May 11;209(3):453-66
pubmed: 25963822
Eur Respir J. 2013 May;41(5):1207-18
pubmed: 23100500
Sci Adv. 2020 Mar 18;6(12):eaay6314
pubmed: 32206714
Eur Respir Rev. 2012 Jun 1;21(124):141-6
pubmed: 22654086
Am J Respir Cell Mol Biol. 2016 Sep;55(3):309-22
pubmed: 27149613
Pancreatology. 2020 Mar;20(2):254-264
pubmed: 31866391
Inflammation. 2004 Dec;28(6):359-64
pubmed: 16245079
Lancet. 2009 Jul 18;374(9685):222-8
pubmed: 19570573
Lancet Respir Med. 2017 Jan;5(1):22-32
pubmed: 27939076
Ocul Immunol Inflamm. 2019;27(6):932-936
pubmed: 29953308
Ann Intern Med. 2001 Jan 16;134(2):136-51
pubmed: 11177318

Auteurs

Angelo Zinellu (A)

Department of Biomedical Sciences, University of Sassari, Sassari, Italy.

Panagiotis Paliogiannis (P)

Department of Medical, Surgical and Experimental Sciences, University of Sassari, Sassari, Italy. panospaliogiannis@gmail.com.

Elisabetta Sotgiu (E)

Department of Biomedical Sciences, University of Sassari, Sassari, Italy.

Sabrina Mellino (S)

Department of Biomedical Sciences, University of Sassari, Sassari, Italy.

Arduino A Mangoni (AA)

Department of Clinical Pharmacology, College of Medicine and Public Health, Flinders University and Flinders Medical Centre, Adelaide, Australia.

Elisabetta Zinellu (E)

Unit of Respiratory Diseases, University Hospital Sassari (AOU), Sassari, Italy.

Silvia Negri (S)

Department of Medical, Surgical and Experimental Sciences, University of Sassari, Sassari, Italy.
Unit of Respiratory Diseases, University Hospital Sassari (AOU), Sassari, Italy.

Claudia Collu (C)

Department of Medical, Surgical and Experimental Sciences, University of Sassari, Sassari, Italy.
Unit of Respiratory Diseases, University Hospital Sassari (AOU), Sassari, Italy.

Gianfranco Pintus (G)

Department of Biomedical Sciences, University of Sassari, Sassari, Italy.
Department of Medical Laboratory Sciences, College of Health Sciences and Sharjah Institute for Medical Research, University of Sharjah, P.O. Box: 27272, Sharjah, United Arab Emirates.

Antonello Serra (A)

Unit of Occupational Medicine, University Hospital Sassari (AOU), Sassari, Italy.

Angelo Maria Pistuddi (AM)

Unit of Occupational Medicine, University Hospital Sassari (AOU), Sassari, Italy.

Ciriaco Carru (C)

Department of Biomedical Sciences, University of Sassari, Sassari, Italy.

Pietro Pirina (P)

Department of Medical, Surgical and Experimental Sciences, University of Sassari, Sassari, Italy.
Unit of Respiratory Diseases, University Hospital Sassari (AOU), Sassari, Italy.

Alessandro G Fois (AG)

Department of Medical, Surgical and Experimental Sciences, University of Sassari, Sassari, Italy.
Unit of Respiratory Diseases, University Hospital Sassari (AOU), Sassari, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH